Pharmaceutical Preparations
| Institution | Shares | Value | Ownership % | Change | Filing Date |
|---|---|---|---|---|---|
| B Group, Inc. | 4.09M | $16.0M | 9.48% | +1.09M | 2026-06-30 |
| VANGUARD CAPITAL MANAGEMENT LLC | 1.62M | $6.0M | 3.75% | +458.0K | 2026-06-30 |
| CITADEL ADVISORS LLC | 930.9K | $3.0M | 2.16% | +906.2K | 2026-06-30 |
| AMERIPRISE FINANCIAL INC | 928.7K | $3.0M | 2.15% | -- | 2026-06-30 |
| Balyasny Asset Management L.P. | 893.9K | $3.0M | 2.07% | -- | 2026-06-30 |
| AdvisorShares Investments LLC | 659.0K | $2.0M | 1.53% | +238.6K | 2026-06-30 |
| COMMONWEALTH EQUITY SERVICES, LLC | 454.4K | $1.0M | 1.05% | -- | 2026-06-30 |
| UBS Group AG | 423.1K | $1.0M | 0.98% | +397.9K | 2026-06-30 |
| GEODE CAPITAL MANAGEMENT, LLC | 314.7K | $1.0M | 0.73% | +4.5K | 2026-06-30 |
| BlackRock, Inc. | 220.5K | -- | 0.51% | +121.5K | 2026-06-30 |
